Home / Drugs / Glyxambi (empagliflozin and linagliptin)

Glyxambi (empagliflozin and linagliptin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

July 2016

WARNINGS AND PRECAUTIONS

Ketoacidosis (addition of the following sentence in first paragraph)

Fatal cases listed

About Tess Bryan

Tess Bryan is an influential Health & Travel blogger helping businesses worldwide to connect with their ideal audience and sharing great citizen journalism. Connect with her via Linkedin to share your story.

Check Also

Custom Nutra Asks a Big Question: Can You Trust What the Supplement Label Says?

When you buy supplements or vitamins, you would generally read the label to make sure …